Literature DB >> 28988953

Meddling with Fate: The Proteasomal Deubiquitinating Enzymes.

Stefanie A H de Poot1, Geng Tian1, Daniel Finley2.   

Abstract

Three deubiquitinating enzymes-Rpn11, Usp14, and Uch37-are associated with the proteasome regulatory particle. These enzymes allow proteasomes to remove ubiquitin from substrates before they are translocated into the core particle to be degraded. Although the translocation channel is too narrow for folded proteins, the force of translocation unfolds them mechanically. As translocation proceeds, ubiquitin chains bound to substrate are drawn to the channel's entry port, where they can impede further translocation. Rpn11, situated over the port, can remove these chains without compromising degradation because substrates must be irreversibly committed to degradation before Rpn11 acts. This coupling between deubiquitination and substrate degradation is ensured by the Ins-1 loop of Rpn11, which controls ubiquitin access to its catalytic site. In contrast to Rpn11, Usp14 and Uch37 can rescue substrates from degradation by promoting substrate dissociation from the proteasome prior to the commitment step. Uch37 is unique in being a component of both the proteasome and a second multisubunit assembly, the INO80 complex. However, only recruitment into the proteasome activates Uch37. Recruitment to the proteasome likewise activates Usp14. However, the influence of Usp14 on the proteasome depends on the substrate, due to its marked preference for proteins that carry multiple ubiquitin chains. Usp14 exerts complex control over the proteasome, suppressing proteasome activity even when inactive in deubiquitination. A major challenge for the field will be to elucidate the specificities of Rpn11, Usp14, and Uch37 in greater depth, employing not only model in vitro substrates but also their endogenous targets.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Rpn11; Uch37; Usp14; deubiquitinating enzymes; proteasome

Mesh:

Substances:

Year:  2017        PMID: 28988953      PMCID: PMC5675770          DOI: 10.1016/j.jmb.2017.09.015

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  157 in total

Review 1.  The increasing complexity of the ubiquitin code.

Authors:  Richard Yau; Michael Rape
Journal:  Nat Cell Biol       Date:  2016-05-27       Impact factor: 28.824

2.  Ubiquitin-specific protease 14 regulates LPS-induced inflammation by increasing ERK1/2 phosphorylation and NF-κB activation.

Authors:  Ningning Liu; Tianyu Kong; Xiaohua Chen; Huan Hu; Hongjiao Gu; Shiming Liu; Xiaohui Chen; Qilin Yang; Aiqun Li; Xuming Xiong; Zhenhui Zhang
Journal:  Mol Cell Biochem       Date:  2017-03-31       Impact factor: 3.396

3.  Loss of Usp14 results in reduced levels of ubiquitin in ataxia mice.

Authors:  Christopher Anderson; Stephen Crimmins; Julie A Wilson; Greg A Korbel; Hidde L Ploegh; Scott M Wilson
Journal:  J Neurochem       Date:  2005-09-29       Impact factor: 5.372

4.  hRpn13/ADRM1/GP110 is a novel proteasome subunit that binds the deubiquitinating enzyme, UCH37.

Authors:  Xiao-Bo Qiu; Song-Ying Ouyang; Chao-Jun Li; Shiying Miao; Linfang Wang; Alfred L Goldberg
Journal:  EMBO J       Date:  2006-11-30       Impact factor: 11.598

5.  Transgenic rescue of ataxia mice reveals a male-specific sterility defect.

Authors:  Stephen Crimmins; Miriam Sutovsky; Ping-Chung Chen; Alexis Huffman; Crystal Wheeler; Deborah A Swing; Kevin Roth; Julie Wilson; Peter Sutovsky; Scott Wilson
Journal:  Dev Biol       Date:  2008-09-27       Impact factor: 3.582

6.  Ubiquitin depletion as a key mediator of toxicity by translational inhibitors.

Authors:  John Hanna; David S Leggett; Daniel Finley
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

7.  An inhibitor of the proteasomal deubiquitinating enzyme USP14 induces tau elimination in cultured neurons.

Authors:  Monica Boselli; Byung-Hoon Lee; Jessica Robert; Miguel A Prado; Sang-Won Min; Chialin Cheng; M Catarina Silva; Changhyun Seong; Suzanne Elsasser; Ketki M Hatle; Timothy C Gahman; Steven P Gygi; Stephen J Haggarty; Li Gan; Randall W King; Daniel Finley
Journal:  J Biol Chem       Date:  2017-09-26       Impact factor: 5.157

8.  Enhancement of proteasome activity by a small-molecule inhibitor of USP14.

Authors:  Byung-Hoon Lee; Min Jae Lee; Soyeon Park; Dong-Chan Oh; Suzanne Elsasser; Ping-Chung Chen; Carlos Gartner; Nevena Dimova; John Hanna; Steven P Gygi; Scott M Wilson; Randall W King; Daniel Finley
Journal:  Nature       Date:  2010-09-09       Impact factor: 49.962

9.  POH1 deubiquitylates and stabilizes E2F1 to promote tumour formation.

Authors:  Boshi Wang; Aihui Ma; Li Zhang; Wei-Lin Jin; Yu Qian; Guiqin Xu; Bijun Qiu; Zhaojuan Yang; Yun Liu; Qiang Xia; Yongzhong Liu
Journal:  Nat Commun       Date:  2015-10-29       Impact factor: 14.919

10.  Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor.

Authors:  Yuning Liao; Ningning Liu; Xianliang Hua; Jianyu Cai; Xiaohong Xia; Xuejun Wang; Hongbiao Huang; Jinbao Liu
Journal:  Cell Death Dis       Date:  2017-02-02       Impact factor: 8.469

View more
  40 in total

1.  Diverse fate of ubiquitin chain moieties: The proximal is degraded with the target, and the distal protects the proximal from removal and recycles.

Authors:  Hao Sun; Sachitanand M Mali; Sumeet K Singh; Roman Meledin; Ashraf Brik; Yong Tae Kwon; Yelena Kravtsova-Ivantsiv; Beatrice Bercovich; Aaron Ciechanover
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-13       Impact factor: 11.205

Review 2.  Protein Degradation and the Pathologic Basis of Disease.

Authors:  John Hanna; Angel Guerra-Moreno; Jessie Ang; Yagmur Micoogullari
Journal:  Am J Pathol       Date:  2018-10-10       Impact factor: 4.307

Review 3.  Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.

Authors:  Barry Boland; Wai Haung Yu; Olga Corti; Bertrand Mollereau; Alexandre Henriques; Erwan Bezard; Greg M Pastores; David C Rubinsztein; Ralph A Nixon; Michael R Duchen; Giovanna R Mallucci; Guido Kroemer; Beth Levine; Eeva-Liisa Eskelinen; Fanny Mochel; Michael Spedding; Caroline Louis; Olivier R Martin; Mark J Millan
Journal:  Nat Rev Drug Discov       Date:  2018-08-17       Impact factor: 84.694

4.  Proteomics of broad deubiquitylase inhibition unmasks redundant enzyme function to reveal substrates and assess enzyme specificity.

Authors:  Valentina Rossio; Joao A Paulo; Joel Chick; Bradley Brasher; Steven P Gygi; Randall W King
Journal:  Cell Chem Biol       Date:  2021-01-07       Impact factor: 8.116

5.  The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.

Authors:  G R Tundo; D Sbardella; A M Santoro; A Coletta; F Oddone; G Grasso; D Milardi; P M Lacal; S Marini; R Purrello; G Graziani; M Coletta
Journal:  Pharmacol Ther       Date:  2020-05-19       Impact factor: 12.310

6.  Activity-Dependent Degradation of the Nascentome by the Neuronal Membrane Proteasome.

Authors:  Kapil V Ramachandran; Jack M Fu; Thomas B Schaffer; Chan Hyun Na; Michael Delannoy; Seth S Margolis
Journal:  Mol Cell       Date:  2018-07-05       Impact factor: 17.970

7.  Proteasome-Bound UCH37/UCHL5 Debranches Ubiquitin Chains to Promote Degradation.

Authors:  Kirandeep K Deol; Sean O Crowe; Jiale Du; Heather A Bisbee; Robert G Guenette; Eric R Strieter
Journal:  Mol Cell       Date:  2020-11-05       Impact factor: 17.970

8.  USP14 regulates DNA damage repair by targeting RNF168-dependent ubiquitination.

Authors:  Arishya Sharma; Turkeya Alswillah; Kamini Singh; Payel Chatterjee; Belinda Willard; Monica Venere; Matthew K Summers; Alexandru Almasan
Journal:  Autophagy       Date:  2018-08-10       Impact factor: 16.016

Review 9.  The Proteasome and Its Network: Engineering for Adaptability.

Authors:  Daniel Finley; Miguel A Prado
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-01-02       Impact factor: 10.005

Review 10.  Breaking the chains: deubiquitylating enzyme specificity begets function.

Authors:  Michael J Clague; Sylvie Urbé; David Komander
Journal:  Nat Rev Mol Cell Biol       Date:  2019-06       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.